| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 2.14e-05 | 13 | 11 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 4.69e-05 | 19 | 11 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | copper ion binding | 8.10e-04 | 78 | 11 | 2 | GO:0005507 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 2.19e-03 | 129 | 11 | 2 | GO:0035591 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 5.94e-03 | 709 | 11 | 3 | GO:0016773 | |
| GeneOntologyMolecularFunction | kinase activity | 7.31e-03 | 764 | 11 | 3 | GO:0016301 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | 6.30e-08 | 16 | 11 | 3 | GO:0010273 | |
| GeneOntologyBiologicalProcess | stress response to copper ion | 6.30e-08 | 16 | 11 | 3 | GO:1990169 | |
| GeneOntologyBiologicalProcess | stress response to metal ion | 1.73e-07 | 22 | 11 | 3 | GO:0097501 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 2.58e-07 | 25 | 11 | 3 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to copper ion | 3.28e-07 | 27 | 11 | 3 | GO:0071280 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 3.67e-07 | 28 | 11 | 3 | GO:0071294 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 1.38e-06 | 43 | 11 | 3 | GO:0071276 | |
| GeneOntologyBiologicalProcess | response to copper ion | 1.38e-06 | 43 | 11 | 3 | GO:0046688 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 1.48e-06 | 44 | 11 | 3 | GO:0006882 | |
| GeneOntologyBiologicalProcess | response to zinc ion | 3.99e-06 | 61 | 11 | 3 | GO:0010043 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 5.55e-06 | 68 | 11 | 3 | GO:0046686 | |
| GeneOntologyBiologicalProcess | cellular response to chromate | 7.23e-06 | 8 | 11 | 2 | GO:0071247 | |
| GeneOntologyBiologicalProcess | response to chromate | 9.29e-06 | 9 | 11 | 2 | GO:0046687 | |
| GeneOntologyBiologicalProcess | detoxification | 8.65e-05 | 170 | 11 | 3 | GO:0098754 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 1.83e-04 | 219 | 11 | 3 | GO:0071248 | |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 1.99e-04 | 40 | 11 | 2 | GO:0007263 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 4.13e-04 | 289 | 11 | 3 | GO:0009636 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.18e-03 | 415 | 11 | 3 | GO:0010038 | |
| GeneOntologyBiologicalProcess | Ras protein signal transduction | 2.03e-03 | 128 | 11 | 2 | GO:0007265 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 2.49e-03 | 538 | 11 | 3 | GO:0007264 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 3.57e-03 | 611 | 11 | 3 | GO:0030003 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 3.76e-03 | 622 | 11 | 3 | GO:0006873 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 3.76e-03 | 622 | 11 | 3 | GO:0098771 | |
| HumanPheno | Abnormal frontalis muscle physiology | 3.47e-06 | 10 | 2 | 2 | HP:3000004 | |
| HumanPheno | Frontalis muscle weakness | 3.47e-06 | 10 | 2 | 2 | HP:0004661 | |
| HumanPheno | Abnormality of occipitofrontalis muscle | 3.47e-06 | 10 | 2 | 2 | HP:0040172 | |
| HumanPheno | Apneic episodes precipitated by illness, fatigue, stress | 5.09e-06 | 12 | 2 | 2 | HP:0002872 | |
| HumanPheno | Narrow jaw | 6.01e-06 | 13 | 2 | 2 | HP:0012801 | |
| HumanPheno | Intermittent episodes of respiratory insufficiency due to muscle weakness | 7.02e-06 | 14 | 2 | 2 | HP:0004889 | |
| HumanPheno | Nasal regurgitation | 7.02e-06 | 14 | 2 | 2 | HP:0011469 | |
| HumanPheno | Choking episodes | 1.05e-05 | 17 | 2 | 2 | HP:0030842 | |
| HumanPheno | Sudden episodic apnea | 1.32e-05 | 19 | 2 | 2 | HP:0002882 | |
| HumanPheno | Episodic respiratory distress | 1.62e-05 | 21 | 2 | 2 | HP:0004885 | |
| HumanPheno | Anti-acetylcholine receptor antibody positivity | 1.78e-05 | 22 | 2 | 2 | HP:6001064 | |
| HumanPheno | Anti-neuromuscular Junction acetylcholine receptor antibody positivity | 1.78e-05 | 22 | 2 | 2 | HP:0030208 | |
| HumanPheno | Staring gaze | 1.78e-05 | 22 | 2 | 2 | HP:0025401 | |
| HumanPheno | Neuropathic spinal arthropathy | 1.95e-05 | 23 | 2 | 2 | HP:0008443 | |
| HumanPheno | Respiratory arrest | 3.13e-05 | 29 | 2 | 2 | HP:0005943 | |
| HumanPheno | Central sleep apnea | 3.58e-05 | 31 | 2 | 2 | HP:0010536 | |
| HumanPheno | EMG: impaired neuromuscular transmission | 4.86e-05 | 36 | 2 | 2 | HP:0100285 | |
| HumanPheno | Motor polyneuropathy | 5.42e-05 | 38 | 2 | 2 | HP:0007178 | |
| HumanPheno | Bulbar palsy | 6.64e-05 | 42 | 2 | 2 | HP:0001283 | |
| HumanPheno | EEG with polyspike wave complexes | 9.07e-05 | 49 | 2 | 2 | HP:0002392 | |
| HumanPheno | Weak cry | 9.07e-05 | 49 | 2 | 2 | HP:0001612 | |
| HumanPheno | Stridor | 9.44e-05 | 50 | 2 | 2 | HP:0010307 | |
| HumanPheno | Spinal rigidity | 1.32e-04 | 59 | 2 | 2 | HP:0003306 | |
| HumanPheno | Abnormal cry | 1.41e-04 | 61 | 2 | 2 | HP:0025429 | |
| HumanPheno | Muscle fiber atrophy | 1.70e-04 | 67 | 2 | 2 | HP:0100295 | |
| HumanPheno | Obstructive sleep apnea | 2.38e-04 | 79 | 2 | 2 | HP:0002870 | |
| HumanPheno | Congenital hip dislocation | 2.69e-04 | 84 | 2 | 2 | HP:0001374 | |
| HumanPheno | Microretrognathia | 2.69e-04 | 84 | 2 | 2 | HP:0000308 | |
| HumanPheno | EEG with spike-wave complexes | 2.95e-04 | 88 | 2 | 2 | HP:0010850 | |
| HumanPheno | Micrognathia | 3.02e-04 | 89 | 2 | 2 | HP:0000210 | |
| HumanPheno | Easy fatigability | 3.16e-04 | 91 | 2 | 2 | HP:0003388 | |
| HumanPheno | Tip-toe gait | 3.16e-04 | 91 | 2 | 2 | HP:0030051 | |
| HumanPheno | Diplopia | 3.37e-04 | 94 | 2 | 2 | HP:0000651 | |
| HumanPheno | Abnormality of binocular vision | 3.37e-04 | 94 | 2 | 2 | HP:0011514 | |
| HumanPheno | Neck muscle weakness | 3.44e-04 | 95 | 2 | 2 | HP:0000467 | |
| HumanPheno | Distal lower limb muscle weakness | 3.52e-04 | 96 | 2 | 2 | HP:0009053 | |
| HumanPheno | Limb-girdle muscle weakness | 4.05e-04 | 103 | 2 | 2 | HP:0003325 | |
| HumanPheno | Respiratory insufficiency due to muscle weakness | 4.05e-04 | 103 | 2 | 2 | HP:0002747 | |
| HumanPheno | Knee flexion contracture | 4.21e-04 | 105 | 2 | 2 | HP:0006380 | |
| HumanPheno | Knee contracture | 4.62e-04 | 110 | 2 | 2 | HP:0034671 | |
| HumanPheno | Hypernasal speech | 4.97e-04 | 114 | 2 | 2 | HP:0001611 | |
| HumanPheno | Weakness of muscles of respiration | 5.14e-04 | 116 | 2 | 2 | HP:0004347 | |
| HumanPheno | Cyanosis | 5.23e-04 | 117 | 2 | 2 | HP:0000961 | |
| HumanPheno | Fatigable weakness | 5.60e-04 | 121 | 2 | 2 | HP:0003473 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 5.69e-04 | 122 | 2 | 2 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 5.69e-04 | 122 | 2 | 2 | HP:0003398 | |
| HumanPheno | Abnormal synaptic transmission | 5.69e-04 | 122 | 2 | 2 | HP:0012535 | |
| HumanPheno | Abnormal eating behavior | 6.27e-04 | 128 | 2 | 2 | HP:0100738 | |
| HumanPheno | EMG: myopathic abnormalities | 6.36e-04 | 129 | 2 | 2 | HP:0003458 | |
| HumanPheno | Waddling gait | 6.46e-04 | 130 | 2 | 2 | HP:0002515 | |
| HumanPheno | Abnormal breath sound | 6.77e-04 | 133 | 2 | 2 | HP:0030829 | |
| HumanPheno | Generalized muscle weakness | 6.87e-04 | 134 | 2 | 2 | HP:0003324 | |
| HumanPheno | Arthrogryposis multiplex congenita | 7.72e-04 | 142 | 2 | 2 | HP:0002804 | |
| HumanPheno | Poor suck | 8.85e-04 | 152 | 2 | 2 | HP:0002033 | |
| HumanPheno | Dysphonia | 9.68e-04 | 159 | 2 | 2 | HP:0001618 | |
| HumanPheno | Congenital contracture | 1.04e-03 | 165 | 2 | 2 | HP:0002803 | |
| HumanPheno | Sleep apnea | 1.08e-03 | 168 | 2 | 2 | HP:0010535 | |
| HumanPheno | Sleep-related breathing disorders | 1.09e-03 | 169 | 2 | 2 | HP:5200283 | |
| HumanPheno | Abnormal morphology of the musculature of the neck | 1.12e-03 | 171 | 2 | 2 | HP:0011006 | |
| HumanPheno | Autoimmune antibody positivity | 1.17e-03 | 175 | 2 | 2 | HP:0030057 | |
| HumanPheno | Pectus carinatum | 1.21e-03 | 178 | 2 | 2 | HP:0000768 | |
| HumanPheno | Kyphoscoliosis | 1.47e-03 | 196 | 2 | 2 | HP:0002751 | |
| HumanPheno | Esotropia | 1.66e-03 | 208 | 2 | 2 | HP:0000565 | |
| HumanPheno | Respiratory distress | 1.96e-03 | 226 | 2 | 2 | HP:0002098 | |
| HumanPheno | Distal amyotrophy | 2.03e-03 | 230 | 2 | 2 | HP:0003693 | |
| HumanPheno | Facial palsy | 2.07e-03 | 232 | 2 | 2 | HP:0010628 | |
| HumanPheno | Abnormal seventh cranial physiology | 2.08e-03 | 233 | 2 | 2 | HP:0010827 | |
| HumanPheno | Decreased fetal movement | 2.10e-03 | 234 | 2 | 2 | HP:0001558 | |
| HumanPheno | Poor head control | 2.12e-03 | 235 | 2 | 2 | HP:0002421 | |
| HumanPheno | Esodeviation | 2.14e-03 | 236 | 2 | 2 | HP:0020045 | |
| HumanPheno | Lower limb muscle weakness | 2.29e-03 | 244 | 2 | 2 | HP:0007340 | |
| HumanPheno | Prenatal movement abnormality | 2.32e-03 | 246 | 2 | 2 | HP:0001557 | |
| HumanPheno | Hip dysplasia | 2.34e-03 | 247 | 2 | 2 | HP:0001385 | |
| HumanPheno | Long face | 2.58e-03 | 259 | 2 | 2 | HP:0000276 | |
| HumanPheno | Hip dislocation | 2.66e-03 | 263 | 2 | 2 | HP:0002827 | |
| HumanPheno | Ophthalmoplegia | 2.70e-03 | 265 | 2 | 2 | HP:0000602 | |
| HumanPheno | Weakness of facial musculature | 2.78e-03 | 269 | 2 | 2 | HP:0030319 | |
| HumanPheno | EEG with generalized epileptiform discharges | 2.80e-03 | 270 | 2 | 2 | HP:0011198 | |
| HumanPheno | Heterotropia | 3.03e-03 | 281 | 2 | 2 | HP:0032012 | |
| HumanPheno | Large face | 3.08e-03 | 283 | 2 | 2 | HP:0100729 | |
| HumanPheno | EMG abnormality | 3.30e-03 | 293 | 2 | 2 | HP:0003457 | |
| HumanPheno | Abnormal consumption behavior | 3.43e-03 | 299 | 2 | 2 | HP:0040202 | |
| HumanPheno | Abnormal muscle fiber morphology | 3.50e-03 | 302 | 2 | 2 | HP:0004303 | |
| HumanPheno | Pes cavus | 3.55e-03 | 304 | 2 | 2 | HP:0001761 | |
| HumanPheno | Abnormal fetal physiology | 3.64e-03 | 308 | 2 | 2 | HP:0034059 | |
| HumanPheno | Polyhydramnios | 3.74e-03 | 312 | 2 | 2 | HP:0001561 | |
| HumanPheno | Areflexia | 3.79e-03 | 314 | 2 | 2 | HP:0001284 | |
| HumanPheno | Lower extremity joint dislocation | 3.89e-03 | 318 | 2 | 2 | HP:0030311 | |
| HumanPheno | Interictal epileptiform activity | 3.91e-03 | 319 | 2 | 2 | HP:0011182 | |
| HumanPheno | Interictal EEG abnormality | 4.06e-03 | 325 | 2 | 2 | HP:0025373 | |
| HumanPheno | Cranial nerve paralysis | 4.16e-03 | 329 | 2 | 2 | HP:0006824 | |
| HumanPheno | Autoimmunity | 4.21e-03 | 331 | 2 | 2 | HP:0002960 | |
| HumanPheno | Abnormal cranial nerve physiology | 4.24e-03 | 332 | 2 | 2 | HP:0031910 | |
| HumanPheno | Proximal muscle weakness | 4.44e-03 | 340 | 2 | 2 | HP:0003701 | |
| HumanPheno | Myopathy | 4.47e-03 | 341 | 2 | 2 | HP:0003198 | |
| HumanPheno | Ophthalmoparesis | 4.71e-03 | 350 | 2 | 2 | HP:0000597 | |
| HumanPheno | Abnormal brainstem morphology | 4.76e-03 | 352 | 2 | 2 | HP:0002363 | |
| HumanPheno | Distal muscle weakness | 4.82e-03 | 354 | 2 | 2 | HP:0002460 | |
| HumanPheno | Limb muscle weakness | 4.95e-03 | 359 | 2 | 2 | HP:0003690 | |
| Domain | Metalthion_dom_vert | 3.33e-08 | 12 | 11 | 3 | IPR023587 | |
| Domain | Metalthion_dom | 3.33e-08 | 12 | 11 | 3 | IPR017854 | |
| Domain | - | 3.33e-08 | 12 | 11 | 3 | 4.10.10.10 | |
| Domain | ZF_DAG_PE_2 | 4.06e-08 | 64 | 11 | 4 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 4.06e-08 | 64 | 11 | 4 | PS00479 | |
| Domain | C1 | 4.33e-08 | 65 | 11 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 4.61e-08 | 66 | 11 | 4 | IPR002219 | |
| Domain | Metalthion_vert | 5.51e-08 | 14 | 11 | 3 | IPR000006 | |
| Domain | Metalthion | 5.51e-08 | 14 | 11 | 3 | IPR003019 | |
| Domain | Metallothio | 5.51e-08 | 14 | 11 | 3 | PF00131 | |
| Domain | KSR1-SAM | 3.15e-07 | 2 | 11 | 2 | PF13543 | |
| Domain | KSR_SAM-like_dom | 3.15e-07 | 2 | 11 | 2 | IPR025561 | |
| Domain | C1_1 | 4.37e-06 | 57 | 11 | 3 | PF00130 | |
| Domain | Metalthion_vert_metal_BS | 1.42e-05 | 10 | 11 | 2 | IPR018064 | |
| Domain | METALLOTHIONEIN_VRT | 2.45e-05 | 13 | 11 | 2 | PS00203 | |
| Domain | Pkinase_Tyr | 2.50e-03 | 129 | 11 | 2 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.85e-03 | 138 | 11 | 2 | IPR001245 | |
| Domain | Ser/Thr_kinase_AS | 1.79e-02 | 357 | 11 | 2 | IPR008271 | |
| Domain | S_TKc | 1.81e-02 | 359 | 11 | 2 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.84e-02 | 362 | 11 | 2 | PS00108 | |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 1.99e-05 | 11 | 9 | 2 | M27543 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 3.28e-05 | 14 | 9 | 2 | M27541 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 2.26e-04 | 36 | 9 | 2 | MM15941 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 2.39e-04 | 37 | 9 | 2 | M39377 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.65e-04 | 39 | 9 | 2 | MM15272 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 2.79e-04 | 40 | 9 | 2 | M27557 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 3.54e-04 | 45 | 9 | 2 | M27623 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 4.91e-04 | 53 | 9 | 2 | M39349 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 7.38e-04 | 65 | 9 | 2 | M38994 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.17e-03 | 82 | 9 | 2 | M27626 | |
| Pathway | WP_TNFALPHA_SIGNALING | 1.47e-03 | 92 | 9 | 2 | M39662 | |
| Pathway | WP_RAS_SIGNALING | 5.74e-03 | 184 | 9 | 2 | M39764 | |
| Pubmed | Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. | 9.09e-08 | 2 | 11 | 2 | 22801368 | |
| Pubmed | KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. | 9.09e-08 | 2 | 11 | 2 | 19883615 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 28180061 | ||
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 20945381 | ||
| Pubmed | KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. | 2.73e-07 | 3 | 11 | 2 | 19560418 | |
| Pubmed | An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis. | 2.73e-07 | 3 | 11 | 2 | 24662736 | |
| Pubmed | 5.45e-07 | 4 | 11 | 2 | 20551211 | ||
| Pubmed | Induction by zinc of specific metallothionein isoforms in human monocytes. | 5.45e-07 | 4 | 11 | 2 | 8119276 | |
| Pubmed | The KSR2-calcineurin complex regulates STIM1-ORAI1 dynamics and store-operated calcium entry (SOCE). | 9.09e-07 | 5 | 11 | 2 | 24672054 | |
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 1.36e-06 | 6 | 11 | 2 | 27086506 | |
| Pubmed | Metallothionein 1 isoform gene expression induced by cadmium in human peripheral blood lymphocytes. | 1.36e-06 | 6 | 11 | 2 | 16827180 | |
| Pubmed | MEK drives BRAF activation through allosteric control of KSR proteins. | 1.91e-06 | 7 | 11 | 2 | 29433126 | |
| Pubmed | Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. | 2.54e-06 | 8 | 11 | 2 | 6941274 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 17114818 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 14627804 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 16930132 | ||
| Pubmed | Isolation and characterization of the mouse metallothionein-I gene. | 2.54e-06 | 8 | 11 | 2 | 6935664 | |
| Pubmed | Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity. | 2.54e-06 | 8 | 11 | 2 | 18815222 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 22819979 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 15139010 | ||
| Pubmed | The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. | 2.54e-06 | 8 | 11 | 2 | 6202573 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 24440343 | ||
| Pubmed | Dietary zinc and metallothionein on small intestinal disaccharidases activity in mice. | 2.54e-06 | 8 | 11 | 2 | 21253395 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 19490933 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 12970870 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 10830785 | ||
| Pubmed | Metallothionein-human GH fusion genes stimulate growth of mice. | 2.54e-06 | 8 | 11 | 2 | 6356363 | |
| Pubmed | Heme-hemopexin-mediated induction of metallothionein gene expression. | 2.54e-06 | 8 | 11 | 2 | 1644822 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 20127815 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 28134760 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 32415999 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 19914257 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 7254320 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 19344729 | ||
| Pubmed | CpG Site-Specific Regulation of Metallothionein-1 Gene Expression. | 2.54e-06 | 8 | 11 | 2 | 32824906 | |
| Pubmed | Differential expression of the metallothionein gene in liver and brain of mice and rats. | 2.54e-06 | 8 | 11 | 2 | 8470112 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 12638735 | ||
| Pubmed | Zinc, immune plasticity, aging, and successful aging: role of metallothionein. | 2.54e-06 | 8 | 11 | 2 | 15247005 | |
| Pubmed | Fine mapping of a mouse metallothionein gene metal response element. | 2.54e-06 | 8 | 11 | 2 | 2725504 | |
| Pubmed | Localization of metallothionein in the brain of rat and mouse. | 2.54e-06 | 8 | 11 | 2 | 1552172 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 24163136 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 27177022 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 15606775 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 22533418 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 19583814 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 10631978 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 11309296 | ||
| Pubmed | Metallothionein-1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance. | 2.54e-06 | 8 | 11 | 2 | 30055006 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 7925998 | ||
| Pubmed | Paraquat reduces natural killer cell activity via metallothionein induction. | 2.54e-06 | 8 | 11 | 2 | 25496228 | |
| Pubmed | Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells. | 2.54e-06 | 8 | 11 | 2 | 26335571 | |
| Pubmed | Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. | 2.54e-06 | 8 | 11 | 2 | 22523246 | |
| Pubmed | Transgenic mouse blastocysts that overexpress metallothionein-I resist cadmium toxicity in vitro. | 2.54e-06 | 8 | 11 | 2 | 8824913 | |
| Pubmed | Mouse liver metallothioneins. Complete amino acid sequence of metallothionein-I. | 2.54e-06 | 8 | 11 | 2 | 914867 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 8415626 | ||
| Pubmed | Protective role of metallothionein against copper depletion. | 2.54e-06 | 8 | 11 | 2 | 16759633 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 6276022 | ||
| Pubmed | Metallothionein isogene transcription in red blood cell precursors from human cord blood. | 2.54e-06 | 8 | 11 | 2 | 11168427 | |
| Pubmed | Hypothermia enhances induction of protective protein metallothionein under ischemia. | 2.54e-06 | 8 | 11 | 2 | 23374901 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 29269399 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 21866758 | ||
| Pubmed | Influence of NH-Sgamma bonding interactions on the structure and dynamics of metallothioneins. | 2.54e-06 | 8 | 11 | 2 | 19609577 | |
| Pubmed | Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering. | 2.54e-06 | 8 | 11 | 2 | 8495976 | |
| Pubmed | Cloning and sequencing of cDNA for mouse liver metallothionein-I. | 2.54e-06 | 8 | 11 | 2 | 6277322 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 33964119 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 33532613 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 7645027 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 21467744 | ||
| Pubmed | Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. | 2.54e-06 | 8 | 11 | 2 | 15039454 | |
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 24284788 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 20056912 | ||
| Pubmed | 2.54e-06 | 8 | 11 | 2 | 19386279 | ||
| Pubmed | Chromosome assignments of genes for rat ceruloplasmin (CP) and metallothionein (MT). | 2.54e-06 | 8 | 11 | 2 | 8404063 | |
| Pubmed | Cloning and characterization of the metallothionein-I gene from mouse LMTK cells. | 2.54e-06 | 8 | 11 | 2 | 2824133 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 22363575 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 1779826 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 16049321 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 16432836 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 30557628 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 10505629 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 1588441 | ||
| Pubmed | DNA variants with telomere probe enable genetic mapping of ends of mouse chromosomes. | 3.27e-06 | 9 | 11 | 2 | 1686839 | |
| Pubmed | Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis. | 3.27e-06 | 9 | 11 | 2 | 22395140 | |
| Pubmed | Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. | 3.27e-06 | 9 | 11 | 2 | 15743795 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 11850030 | ||
| Pubmed | Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength. | 3.27e-06 | 9 | 11 | 2 | 27956698 | |
| Pubmed | Regulation, linkage, and sequence of mouse metallothionein I and II genes. | 3.27e-06 | 9 | 11 | 2 | 6095054 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 28426713 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 18449439 | ||
| Pubmed | Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice. | 3.27e-06 | 9 | 11 | 2 | 10426817 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 32918239 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 15735556 | ||
| Pubmed | Atrophy of large myelinated axons in metallothionein-I, II knockout mice. | 3.27e-06 | 9 | 11 | 2 | 16133945 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 21913972 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 15979673 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 15306638 | ||
| Pubmed | Cytoprotection by metallothionein against gastroduodenal mucosal injury caused by ethanol in mice. | 3.27e-06 | 9 | 11 | 2 | 10744072 | |
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 9176863 | ||
| Pubmed | 3.27e-06 | 9 | 11 | 2 | 12801924 | ||
| Pubmed | Metallothionein deficiency aggravates depleted uranium-induced nephrotoxicity. | 3.27e-06 | 9 | 11 | 2 | 26148447 | |
| Interaction | SPINK7 interactions | 3.77e-05 | 19 | 10 | 2 | int:SPINK7 | |
| Cytoband | 16q13 | 3.27e-05 | 36 | 11 | 2 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 4.05e-05 | 40 | 11 | 2 | chr16q13 | |
| GeneFamily | Metallothioneins | 1.18e-07 | 19 | 10 | 3 | 638 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.75e-06 | 5 | 10 | 2 | 1157 | |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 4.48e-06 | 8 | 11 | 2 | M41082 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 6.33e-06 | 90 | 11 | 3 | M40267 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 1.68e-05 | 15 | 11 | 2 | M1589 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 3.68e-05 | 22 | 11 | 2 | MM1299 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST | 4.78e-05 | 25 | 11 | 2 | M45753 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 5.59e-05 | 27 | 11 | 2 | MM643 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 6.02e-05 | 28 | 11 | 2 | MM487 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN | 6.50e-05 | 196 | 11 | 3 | M8003 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 6.50e-05 | 196 | 11 | 3 | M4514 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 6.60e-05 | 197 | 11 | 3 | M7543 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP | 6.70e-05 | 198 | 11 | 3 | M5846 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN | 6.80e-05 | 199 | 11 | 3 | M9920 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP | 6.80e-05 | 199 | 11 | 3 | M9915 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP | 6.80e-05 | 199 | 11 | 3 | M7951 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN | 6.90e-05 | 200 | 11 | 3 | M7595 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 6.90e-05 | 200 | 11 | 3 | M3279 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 6.90e-05 | 200 | 11 | 3 | M4512 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN | 6.90e-05 | 200 | 11 | 3 | M4529 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP | 6.90e-05 | 200 | 11 | 3 | M9900 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 6.90e-05 | 200 | 11 | 3 | M9909 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 1.12e-04 | 38 | 11 | 2 | MM1161 | |
| Coexpression | BUSSLINGER_DUODENAL_BCHE_CELLS | 1.43e-04 | 43 | 11 | 2 | M40032 | |
| Coexpression | HOUSTIS_ROS | 1.50e-04 | 44 | 11 | 2 | MM1142 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 1.64e-04 | 46 | 11 | 2 | MM640 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 1.79e-04 | 48 | 11 | 2 | MM649 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 2.02e-04 | 51 | 11 | 2 | MM794 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 2.10e-04 | 52 | 11 | 2 | MM442 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 2.10e-04 | 52 | 11 | 2 | MM628 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 2.26e-04 | 54 | 11 | 2 | MM1195 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 2.26e-04 | 54 | 11 | 2 | M2904 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 2.26e-04 | 54 | 11 | 2 | MM715 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 2.61e-04 | 58 | 11 | 2 | MM703 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 2.70e-04 | 59 | 11 | 2 | MM952 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 3.08e-04 | 63 | 11 | 2 | M2024 | |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 3.81e-04 | 70 | 11 | 2 | M18667 | |
| Coexpression | ODONNELL_METASTASIS_UP | 4.49e-04 | 76 | 11 | 2 | M265 | |
| Coexpression | GHANDHI_BYSTANDER_IRRADIATION_UP | 5.48e-04 | 84 | 11 | 2 | M2597 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 5.48e-04 | 84 | 11 | 2 | MM873 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 6.71e-04 | 93 | 11 | 2 | MM850 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 7.29e-04 | 97 | 11 | 2 | MM16605 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 7.29e-04 | 97 | 11 | 2 | M40301 | |
| Coexpression | BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS | 7.75e-04 | 100 | 11 | 2 | M40011 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 7.75e-04 | 100 | 11 | 2 | MM514 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_UP | 8.54e-04 | 105 | 11 | 2 | M2591 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE | 1.01e-03 | 114 | 11 | 2 | M45759 | |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 1.09e-03 | 119 | 11 | 2 | M41139 | |
| Coexpression | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE | 1.17e-03 | 123 | 11 | 2 | M1784 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 1.21e-03 | 125 | 11 | 2 | MM1065 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 1.23e-03 | 126 | 11 | 2 | MM3711 | |
| Coexpression | MA_RAT_AGING_UP | 1.24e-03 | 127 | 11 | 2 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 1.26e-03 | 128 | 11 | 2 | MM3838 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 1.32e-03 | 131 | 11 | 2 | MM1127 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 1.43e-03 | 136 | 11 | 2 | MM3747 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 1.47e-03 | 138 | 11 | 2 | MM1047 | |
| Coexpression | PECE_MAMMARY_STEM_CELL_UP | 1.49e-03 | 139 | 11 | 2 | M2534 | |
| Coexpression | CSR_LATE_UP.V1_UP | 2.11e-03 | 166 | 11 | 2 | M2660 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS | 2.32e-03 | 174 | 11 | 2 | M40276 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 2.34e-03 | 175 | 11 | 2 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 2.34e-03 | 175 | 11 | 2 | MM501 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 2.37e-03 | 176 | 11 | 2 | MM1048 | |
| Coexpression | WU_CELL_MIGRATION | 2.56e-03 | 183 | 11 | 2 | M2001 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 2.61e-03 | 185 | 11 | 2 | MM1115 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 2.64e-03 | 186 | 11 | 2 | MM498 | |
| Coexpression | GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN | 2.64e-03 | 186 | 11 | 2 | M3290 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS | 2.70e-03 | 188 | 11 | 2 | M40287 | |
| Coexpression | GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN | 2.73e-03 | 189 | 11 | 2 | M9724 | |
| Coexpression | GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN | 2.84e-03 | 193 | 11 | 2 | M9727 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP | 2.87e-03 | 194 | 11 | 2 | M5852 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN | 2.87e-03 | 194 | 11 | 2 | M7942 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP | 2.93e-03 | 196 | 11 | 2 | M10014 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 2.93e-03 | 196 | 11 | 2 | M7124 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 2.93e-03 | 196 | 11 | 2 | MM3746 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN | 2.93e-03 | 196 | 11 | 2 | M5504 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP | 2.96e-03 | 197 | 11 | 2 | M5363 | |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | 2.99e-03 | 198 | 11 | 2 | M8152 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP | 2.99e-03 | 198 | 11 | 2 | M6106 | |
| Coexpression | GSE25087_TREG_VS_TCONV_FETUS_UP | 2.99e-03 | 198 | 11 | 2 | M4647 | |
| Coexpression | GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP | 2.99e-03 | 198 | 11 | 2 | M7702 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN | 2.99e-03 | 198 | 11 | 2 | M5307 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 3.02e-03 | 199 | 11 | 2 | M10018 | |
| Coexpression | GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN | 3.02e-03 | 199 | 11 | 2 | M3093 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 3.02e-03 | 199 | 11 | 2 | M5235 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 3.02e-03 | 199 | 11 | 2 | M4635 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN | 3.02e-03 | 199 | 11 | 2 | M4640 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN | 3.05e-03 | 200 | 11 | 2 | M3408 | |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP | 3.05e-03 | 200 | 11 | 2 | M5394 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN | 3.05e-03 | 200 | 11 | 2 | M5156 | |
| Coexpression | GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP | 3.05e-03 | 200 | 11 | 2 | M9551 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 3.05e-03 | 200 | 11 | 2 | M5228 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 3.05e-03 | 200 | 11 | 2 | M5247 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 3.05e-03 | 200 | 11 | 2 | M4299 | |
| Coexpression | DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS | 3.23e-03 | 206 | 11 | 2 | M40237 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_22 | 3.38e-03 | 211 | 11 | 2 | MM17089 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 3.41e-03 | 212 | 11 | 2 | MM3816 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 3.64e-03 | 219 | 11 | 2 | M262 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 3.80e-03 | 224 | 11 | 2 | MM3767 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 3.83e-03 | 225 | 11 | 2 | MM496 | |
| Coexpression | AIZARANI_LIVER_C14_HEPATOCYTES_2 | 3.87e-03 | 226 | 11 | 2 | M39118 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | 3.99e-03 | 807 | 11 | 3 | M16651 | |
| CoexpressionAtlas | SC blastocyst_vs_SC fibroblast-Confounder_removed-fold2.0_adjp0.05 | 8.67e-09 | 9 | 11 | 3 | PCBC_ratio_SC blastocyst_vs_SC fibroblast_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_lenti Cre-excised-Confounder_removed-fold2.0_adjp0.05 | 5.12e-06 | 7 | 11 | 2 | PCBC_ratio_ESC_vs_iPSC_method-lenti Cre-excised_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-method_NA_vs_Pluripotent Stem Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 6.82e-06 | 8 | 11 | 2 | PCBC_ratio_ESC_vs_iPSC_method-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OSKM-Confounder_removed-fold2.0_adjp0.05 | 6.82e-06 | 8 | 11 | 2 | PCBC_ratio_ESC_vs_iPSC_method-OSKM_cfr-2X-p05 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OS-NL-Confounder_removed-fold2.0_adjp0.05 | 7.70e-06 | 78 | 11 | 3 | PCBC_ratio_ESC_vs_iPSC_method-OS-NL_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | 7.00e-05 | 163 | 11 | 3 | Arv_SC-hpx_blastocyst_500_K2 | |
| CoexpressionAtlas | SC blastocyst_vs_SC amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 7.88e-05 | 26 | 11 | 2 | PCBC_ratio_SC blastocyst_vs_SC amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | 8.65e-05 | 175 | 11 | 3 | Arv_SC-H9hpx_500_K3 | |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.56e-05 | 181 | 11 | 3 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | 9.87e-05 | 183 | 11 | 3 | Arv_SC-HD_1000_K3 | |
| CoexpressionAtlas | SC blastocyst_vs_SC bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.28e-04 | 33 | 11 | 2 | PCBC_ratio_SC blastocyst_vs_SC bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.93e-04 | 613 | 11 | 4 | ratio_SC_vs_EB_1000_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.31e-04 | 244 | 11 | 3 | Arv_SC-H9hpx_1000_K4 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500_k-means-cluster#5 | 2.85e-04 | 262 | 11 | 3 | ratio_SC_vs_DE_500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.98e-04 | 266 | 11 | 3 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.93e-04 | 316 | 11 | 3 | JC_iEC_2500_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.59e-04 | 349 | 11 | 3 | ratio_SC_vs_DE_1000_K4 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.02e-04 | 860 | 11 | 4 | ratio_SC_vs_ECTO_2500_K2 | |
| CoexpressionAtlas | SC-LF blastocyst_vs_SC blastocyst-Confounder_removed-fold2.0_adjp0.05 | 9.30e-04 | 393 | 11 | 3 | PCBC_ratio_SC-LF blastocyst_vs_SC blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.00e-03 | 945 | 11 | 4 | Arv_SC-hpx_blastocyst_2500_K2 | |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 1.02e-03 | 406 | 11 | 3 | PCBC_ratio_SC_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.14e-03 | 978 | 11 | 4 | ratio_SC_vs_EB_2500_K5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.15e-03 | 981 | 11 | 4 | Arv_SC-H9hpx_2500_K5 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | PCBC_ratio_SC_vs_ECTO_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | PCBC_ratio_SC_vs_EB_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | PCBC_ratio_SC_vs_DE_100 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | Arv_SC-H9hpx_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | PCBC_ratio_SC_vs_MESO-5_100 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_100 | 1.15e-03 | 99 | 11 | 2 | Arv_SC-hpx_blastocyst_100 | |
| CoexpressionAtlas | ratio_StemCell_vs_EmbryoidBody_top-relative-expression-ranked_1000 | 1.16e-03 | 984 | 11 | 4 | PCBC_ratio_SC_vs_EB_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_CD34+_top-relative-expression-ranked_1000 | 1.16e-03 | 984 | 11 | 4 | PCBC_SC_CD34+_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 1.17e-03 | 986 | 11 | 4 | Arv_SC_fibroblast_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | 1.17e-03 | 986 | 11 | 4 | Arv_SC-HD_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | 1.18e-03 | 987 | 11 | 4 | Arv_SC-H9hpx_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 1.18e-03 | 987 | 11 | 4 | Arv_SC-hpx_blastocyst_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 1.20e-03 | 993 | 11 | 4 | PCBC_SC_blastocyst_1000 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | 1.78e-03 | 492 | 11 | 3 | Arv_SC-H9hpx_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.78e-03 | 492 | 11 | 3 | Arv_SC-hpx_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.80e-03 | 494 | 11 | 3 | PCBC_SC_blastocyst_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.81e-03 | 1108 | 11 | 4 | Arv_SC_fibroblast_2500_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_500 | 1.83e-03 | 497 | 11 | 3 | PCBC_ratio_SC_vs_DE_500 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.84e-03 | 1113 | 11 | 4 | Arv_SC-HD_2500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | 1.86e-03 | 126 | 11 | 2 | Arv_SC-HD_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.09e-03 | 1152 | 11 | 4 | Arv_SC-LF_2500_K5 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Ectoderm_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.12e-03 | 523 | 11 | 3 | ratio_SC_vs_ECTO_1000_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | 2.25e-03 | 139 | 11 | 2 | Arv_SC_fibroblast_500_K3 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.32e-03 | 540 | 11 | 3 | ratio_SC_vs_MESO_1000_K5 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.45e-03 | 145 | 11 | 2 | JC_iEC_1000_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.49e-03 | 554 | 11 | 3 | Arv_SC_fibroblast_1000_K2 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_2500_k-means-cluster#1 | 3.34e-03 | 614 | 11 | 3 | ratio_SC_vs_DE_2500_K1 | |
| CoexpressionAtlas | AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.36e-03 | 675 | 11 | 3 | Arv_SC-LF_1000_K3 | |
| CoexpressionAtlas | cerebral cortex | 4.58e-03 | 1428 | 11 | 4 | cerebral cortex | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.31e-06 | 145 | 11 | 3 | 1f61987aa7d5fe63004c4a75cb691f83989fc9a5 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.65e-06 | 177 | 11 | 3 | 1f5b6498364b2017c4d49cd337d6e91c8e4f840d | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.98e-06 | 179 | 11 | 3 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 183 | 11 | 3 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-05 | 184 | 11 | 3 | 2b83c7a808e97abf836f53aa3243543c8f6762fb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 188 | 11 | 3 | ed074572e61d97c139fb1636a78c9b71e2c44ce0 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 191 | 11 | 3 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-05 | 192 | 11 | 3 | 1a3d95a9801cc4569b67fa652b2af46c4dedbaef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 195 | 11 | 3 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 196 | 11 | 3 | 3cf73ed99f3efa76b632c16a8b98b6b7758ff63f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 197 | 11 | 3 | eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 197 | 11 | 3 | 291458becbf90e9dda22ea069df7f9a45d827bcd | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 197 | 11 | 3 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-05 | 197 | 11 | 3 | c6645db1bfb5a352cfbb8d83fd1929dcfd41e216 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.35e-05 | 198 | 11 | 3 | ebc064dede536eda7715af0675fd4e657ff4ac5d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 198 | 11 | 3 | 8777117249077d4964dd7566aebde7c443475c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 198 | 11 | 3 | 7db113a6e7962ff26c1e1a43baa1a4230cf5f393 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-05 | 198 | 11 | 3 | 36a60397f49f5381ae377155b73e1891448846b7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 198 | 11 | 3 | 64d73804902a043bdf66b413b769e853d111c033 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.37e-05 | 199 | 11 | 3 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 199 | 11 | 3 | 8fcb32eee0ec0dd88209e723a6f82f425c73ca40 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-04 | 108 | 11 | 2 | ee924deacd14ea404fda80ed633960143fd474c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-04 | 114 | 11 | 2 | b350140b389f8762c77a37df473081e1127a8972 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.28e-04 | 127 | 11 | 2 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.55e-04 | 131 | 11 | 2 | c48c4fb14b31908734bb0c44e1bd124b01df2a0b | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Medullary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.04e-04 | 138 | 11 | 2 | 7931dda2843d8bfe0e54111cc65aed1a891fe4b2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related-Oligodendrocyte/OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-04 | 142 | 11 | 2 | 43e72e4b9ae33768672ef90c8bbfd2ca1818c746 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-04 | 142 | 11 | 2 | d2d150e3019a5b7b143e50b1c1c2b6764abf36bf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-04 | 146 | 11 | 2 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.72e-04 | 147 | 11 | 2 | 2d9044ddf01b6838a44a4518b442d7e7cb0bf910 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.11e-04 | 152 | 11 | 2 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-04 | 153 | 11 | 2 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-04 | 158 | 11 | 2 | ab707bfe782c667b252b488ad1d7efd49cf0a899 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.60e-04 | 158 | 11 | 2 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-5|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.60e-04 | 158 | 11 | 2 | 34b284a62cc3fb90429ce579fd8cb8a60178091b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-04 | 158 | 11 | 2 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-04 | 160 | 11 | 2 | a494001b1f6dec33624f98fa3c24bad6988d0425 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.85e-04 | 161 | 11 | 2 | 6079de6cc4f2aec4091d0fac531fda9a441a70b1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.85e-04 | 161 | 11 | 2 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-04 | 162 | 11 | 2 | 768a566e76923323c1f197f60bab472a8784490b | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-04 | 163 | 11 | 2 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.11e-04 | 164 | 11 | 2 | f2b4d69ee994977275db5ad6d38f681cfe827db0 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.19e-04 | 165 | 11 | 2 | a040d18e4ba6da266440ad0b79990918770bfa7d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 166 | 11 | 2 | fe006c67a96ffa5a84fba2db96228234668b2a79 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.28e-04 | 166 | 11 | 2 | 8d5d09f25e8903d481c2097fed435e69d42ccdb5 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.37e-04 | 167 | 11 | 2 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-04 | 168 | 11 | 2 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.46e-04 | 168 | 11 | 2 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-04 | 169 | 11 | 2 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-04 | 169 | 11 | 2 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-04 | 169 | 11 | 2 | 3e267ec9f884df326315500dfd751b04a3dd91bd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.54e-04 | 169 | 11 | 2 | 1dfaf9a6b433a5ee86a11962af188978c2543278 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-04 | 171 | 11 | 2 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.72e-04 | 171 | 11 | 2 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-04 | 171 | 11 | 2 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.72e-04 | 171 | 11 | 2 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-04 | 171 | 11 | 2 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-04 | 171 | 11 | 2 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.72e-04 | 171 | 11 | 2 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 173 | 11 | 2 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.90e-04 | 173 | 11 | 2 | 8407c9156ab35900858de5273586129d7e283c5b | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 173 | 11 | 2 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-04 | 173 | 11 | 2 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.90e-04 | 173 | 11 | 2 | 021457c7bdb55de7351e43322d360e8fd7061658 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.99e-04 | 174 | 11 | 2 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.99e-04 | 174 | 11 | 2 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.99e-04 | 174 | 11 | 2 | b4483d7d9f22f09ed7fa0b72305434a47ccaade0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.09e-04 | 175 | 11 | 2 | 6759d200a133034756de9cdf2d5daceca927aac9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive-Alveolar_macrophage_MT-positive_L.1.0.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.09e-04 | 175 | 11 | 2 | b227d4499274fb63b193d34de7f2d812e283e79d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_MT-positive|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.09e-04 | 175 | 11 | 2 | 308ee4ef7b9ecea68efca011ef91aed0f1be0eca | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.18e-04 | 176 | 11 | 2 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-04 | 177 | 11 | 2 | 191c14e0ef162536028b841f3759aaddef59b49d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-04 | 177 | 11 | 2 | 5bccc7a74019eae8afd977a9c9134d884857ac27 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Erythrophagocytic_macrophages|Lung / Manually curated celltypes from each tissue | 8.36e-04 | 178 | 11 | 2 | b63cee443cc1b7416112bf610d7c9d41e4fa37ed | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.36e-04 | 178 | 11 | 2 | 4813d6509738f088c12ebf395b70d496af04649a | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.36e-04 | 178 | 11 | 2 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-04 | 179 | 11 | 2 | d96741c5c551e36421b2ad938072ab7d506c3835 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 17ba1eedb6ebf039d3b11d099351d0ac6363c8d1 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 7046f0a426e45fe1b41a25721ee1e33f6fc7f9e3 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-04 | 179 | 11 | 2 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.46e-04 | 179 | 11 | 2 | d5e3e7f1cd8f683f39a7416f12af7e766dcbead8 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | 0e22e840f43ca81a7543dcf33ec17a741cdf7f37 | |
| ToppCell | TCGA-Liver-Solid_Tissue_Normal-Liver-Liver_normal_tissue-2|TCGA-Liver / Sample_Type by Project: Shred V9 | 8.46e-04 | 179 | 11 | 2 | a20bb3ace5be10c5aef330e9268c0ba55f8fee23 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.46e-04 | 179 | 11 | 2 | b8ca29aebd25ebac441bebd769bbf98c536d3166 | |
| ToppCell | 15-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 8.46e-04 | 179 | 11 | 2 | bc04789f0fbd293fdcea66acba8cf227af251b7a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 180 | 11 | 2 | 7d3d5608647b6e684e8e185993d106a38c53e76a | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue | 8.55e-04 | 180 | 11 | 2 | daf69a548ed7c6f285a6adcff00f99aa22f9d6a5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.64e-04 | 181 | 11 | 2 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.64e-04 | 181 | 11 | 2 | d74ee84146a72fd7cddf287f2e66d47d2c683bc4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 4 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 4 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 4 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE | |
| Computational | Genes in the cancer module 321. | 6.37e-04 | 112 | 4 | 2 | MODULE_321 | |
| Computational | Metal / Ca ion binding. | 8.97e-04 | 133 | 4 | 2 | MODULE_324 | |
| Drug | MeOBGDTC | 1.16e-05 | 11 | 11 | 2 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 1.65e-05 | 13 | 11 | 2 | CID006437871 | |
| Drug | Cadmium-thionein | 1.92e-05 | 14 | 11 | 2 | CID000198548 | |
| Drug | diamsar | 1.92e-05 | 14 | 11 | 2 | CID000146286 | |
| Drug | MT45 | 2.22e-05 | 15 | 11 | 2 | CID000431865 | |
| Drug | urs-12-ene-3beta,28-diol | 2.22e-05 | 15 | 11 | 2 | CID000092802 | |
| Drug | ZnATP | 2.87e-05 | 17 | 11 | 2 | CID006455240 | |
| Drug | tolmetin glucuronide | 2.87e-05 | 17 | 11 | 2 | ctd:C056583 | |
| Drug | bismuth nitrate | 2.87e-05 | 17 | 11 | 2 | CID000107711 | |
| Drug | azelaic bishydroxamic acid | 2.87e-05 | 17 | 11 | 2 | CID000065268 | |
| Drug | zomepirac glucuronide | 3.23e-05 | 18 | 11 | 2 | ctd:C027368 | |
| Drug | AC1O3QMZ | 3.61e-05 | 19 | 11 | 2 | CID006334573 | |
| Drug | motexafin gadolinium | 4.10e-05 | 146 | 11 | 3 | ctd:C437683 | |
| Drug | cadmium oxide | 4.43e-05 | 21 | 11 | 2 | CID000014782 | |
| Drug | 4-(2-pyridylazo)resorcinol | 4.88e-05 | 22 | 11 | 2 | CID005370169 | |
| Drug | zinc hydroxide | 4.88e-05 | 22 | 11 | 2 | CID000062742 | |
| Drug | manganese sulfate monohydrate | 5.34e-05 | 23 | 11 | 2 | CID000166832 | |
| Drug | Zinc Acetate | 6.02e-05 | 166 | 11 | 3 | ctd:D019345 | |
| Drug | hinokitiol | 6.33e-05 | 25 | 11 | 2 | CID000003611 | |
| Drug | BGDTC | 6.85e-05 | 26 | 11 | 2 | CID000105107 | |
| Drug | MT20 | 6.85e-05 | 26 | 11 | 2 | CID003025942 | |
| Drug | Oral-Turinabol | 7.40e-05 | 27 | 11 | 2 | CID000098521 | |
| Drug | Ormaplatino | 9.79e-05 | 31 | 11 | 2 | CID006434704 | |
| Drug | alpha-hederin | 1.04e-04 | 32 | 11 | 2 | CID000073296 | |
| Drug | Zinquin | 1.11e-04 | 33 | 11 | 2 | CID000132933 | |
| Drug | rhodanine | 1.18e-04 | 34 | 11 | 2 | CID001201546 | |
| Drug | p-hydroxyphenyllactic acid | 1.32e-04 | 36 | 11 | 2 | CID000009378 | |
| Drug | genistin | 1.48e-04 | 38 | 11 | 2 | CID005281377 | |
| Drug | arsenic(III | 1.64e-04 | 40 | 11 | 2 | CID000104734 | |
| Drug | bismuth | 1.81e-04 | 42 | 11 | 2 | CID000105143 | |
| Drug | trans-DDP | 1.99e-04 | 44 | 11 | 2 | CID000084691 | |
| Drug | AC1L45V9 | 2.08e-04 | 45 | 11 | 2 | CID000151205 | |
| Drug | trien | 2.17e-04 | 46 | 11 | 2 | CID000005565 | |
| Drug | midodrine | 2.27e-04 | 47 | 11 | 2 | CID000004195 | |
| Drug | octachloronaphthalene | 2.27e-04 | 47 | 11 | 2 | CID000016692 | |
| Drug | dimercaprol | 2.36e-04 | 48 | 11 | 2 | CID000003080 | |
| Drug | DL-propargylglycine | 2.36e-04 | 48 | 11 | 2 | CID000095575 | |
| Drug | elesclomol | 2.46e-04 | 49 | 11 | 2 | ctd:C512195 | |
| Drug | dimethylmercury | 2.78e-04 | 52 | 11 | 2 | CID000011645 | |
| Drug | oleanolic acid | 2.78e-04 | 52 | 11 | 2 | CID000010494 | |
| Drug | auranofin | 2.78e-04 | 52 | 11 | 2 | CID006918453 | |
| Drug | Disperse Blue 7 | 3.82e-04 | 61 | 11 | 2 | CID000018514 | |
| Drug | tetrathiomolybdate | 3.82e-04 | 61 | 11 | 2 | CID005245480 | |
| Drug | caffeic acid phenethyl ester | 3.84e-04 | 311 | 11 | 3 | ctd:C055494 | |
| Drug | fenpropathrin | 3.95e-04 | 62 | 11 | 2 | CID000047326 | |
| Drug | ZnSO4.7H2O | 4.08e-04 | 63 | 11 | 2 | CID000062639 | |
| Drug | L-beta-aspartyl phosphate | 4.89e-04 | 69 | 11 | 2 | CID000000832 | |
| Drug | zinc sulfate | 4.89e-04 | 69 | 11 | 2 | CID000024424 | |
| Drug | Organoselenium Compounds | 5.18e-04 | 71 | 11 | 2 | ctd:D016566 | |
| Drug | fluoroacetic acid | 5.32e-04 | 72 | 11 | 2 | CID000005236 | |
| Drug | ursolic acid | 5.32e-04 | 72 | 11 | 2 | CID000064945 | |
| Drug | Fe-NTA | 5.47e-04 | 73 | 11 | 2 | CID000027880 | |
| Drug | selenium | 6.57e-04 | 80 | 11 | 2 | CID006326970 | |
| Drug | p-Chloromercuribenzoic Acid | 6.62e-04 | 908 | 11 | 4 | ctd:D020245 | |
| Drug | zinc chloride | 6.78e-04 | 378 | 11 | 3 | ctd:C016837 | |
| Drug | acetylbetulinic acid | 7.94e-04 | 88 | 11 | 2 | CID000289984 | |
| Drug | CuSO4 | 8.67e-04 | 92 | 11 | 2 | CID000024462 | |
| Drug | S-nitrosocysteine | 8.86e-04 | 93 | 11 | 2 | CID003359494 | |
| Drug | CdCl2 | 9.83e-04 | 98 | 11 | 2 | CID000024947 | |
| Drug | rutin | 9.83e-04 | 98 | 11 | 2 | CID005280805 | |
| Drug | TPEN | 1.02e-03 | 100 | 11 | 2 | CID000005519 | |
| Drug | diethyldithiocarbamate | 1.04e-03 | 101 | 11 | 2 | CID000008987 | |
| Drug | p-terphenyl | 1.09e-03 | 103 | 11 | 2 | CID000007115 | |
| Drug | bis-N,N-dimethylamino-2-(N-methylpyrrolyl)methyl cyclopentadienyl titanium (IV) | 1.11e-03 | 104 | 11 | 2 | ctd:C551172 | |
| Drug | fluconazole | 1.17e-03 | 107 | 11 | 2 | CID000003365 | |
| Drug | zinc superoxide | 1.19e-03 | 108 | 11 | 2 | CID000014809 | |
| Drug | thiobarbituric acid | 1.42e-03 | 118 | 11 | 2 | CID002723628 | |
| Drug | NiCl2 | 1.44e-03 | 119 | 11 | 2 | CID000024385 | |
| Drug | azathioprine | 1.47e-03 | 120 | 11 | 2 | CID000002265 | |
| Drug | bathocuproine sulfonate | 1.49e-03 | 121 | 11 | 2 | ctd:C028559 | |
| Drug | isopropanol | 1.52e-03 | 122 | 11 | 2 | CID000003776 | |
| Drug | AC1L1Z2L | 1.54e-03 | 123 | 11 | 2 | CID000012201 | |
| Drug | arsenate | 1.85e-03 | 135 | 11 | 2 | CID000000233 | |
| Drug | acrolein | 1.88e-03 | 136 | 11 | 2 | CID000007847 | |
| Drug | DL-penicillamine | 1.96e-03 | 139 | 11 | 2 | CID000004727 | |
| Drug | C8-ceramide | 2.06e-03 | 556 | 11 | 3 | CID000002508 | |
| Drug | K-Cl | 2.18e-03 | 567 | 11 | 3 | CID000004873 | |
| Drug | vanadium | 2.25e-03 | 149 | 11 | 2 | CID000023990 | |
| Drug | lead compounds | 2.28e-03 | 150 | 11 | 2 | CID000073212 | |
| Drug | 5,5'-dithiobis(2-nitrobenzoic acid | 2.49e-03 | 157 | 11 | 2 | CID000006254 | |
| Drug | dihydrochloride | 2.56e-03 | 159 | 11 | 2 | CID000070978 | |
| Drug | Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.72e-03 | 164 | 11 | 2 | 7188_UP | |
| Drug | XK234 | 2.82e-03 | 167 | 11 | 2 | CID000454923 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.95e-03 | 171 | 11 | 2 | 3318_UP | |
| Drug | silver nanoparticles | 2.98e-03 | 172 | 11 | 2 | CID000023954 | |
| Drug | sarcolysin | 2.98e-03 | 172 | 11 | 2 | CID000004053 | |
| Drug | 1,1'-azobis(N,N-dimethylformamide | 3.02e-03 | 173 | 11 | 2 | CID000004278 | |
| Drug | selenide ion | 3.19e-03 | 178 | 11 | 2 | CID000107674 | |
| Drug | molybdenum | 3.30e-03 | 181 | 11 | 2 | CID000023932 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 3.30e-03 | 181 | 11 | 2 | 1236_UP | |
| Drug | platinum | 3.37e-03 | 183 | 11 | 2 | CID000023939 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 3.48e-03 | 186 | 11 | 2 | 5566_UP | |
| Drug | zinc chloride (ZnCl2 | 3.48e-03 | 186 | 11 | 2 | CID000005727 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.51e-03 | 187 | 11 | 2 | 5258_UP | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 3.63e-03 | 190 | 11 | 2 | 612_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 3.63e-03 | 190 | 11 | 2 | 4155_UP | |
| Disease | congenital myasthenic syndrome (is_implicated_in) | 6.20e-07 | 4 | 10 | 2 | DOID:3635 (is_implicated_in) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.76e-05 | 19 | 10 | 2 | C0751884 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 7.35e-04 | 121 | 10 | 2 | EFO_0004612, EFO_0005271 | |
| Disease | Drugs used in diabetes use measurement | 3.20e-03 | 255 | 10 | 2 | EFO_0009924 | |
| Disease | nicotine dependence symptom count | 3.97e-03 | 285 | 10 | 2 | EFO_0009262 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.51e-03 | 447 | 10 | 2 | EFO_0000694, MONDO_0100096 | |
| Disease | PR interval | 1.16e-02 | 495 | 10 | 2 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGSCKCKKCKCTSCK | 16 | P0DM35 | |
| LKCKNCKLKCHNKCT | 436 | Q6VAB6 | |
| VKCKHCRLKCHNKCT | 371 | Q8IVT5 | |
| AGSCKCKKCKCTSCK | 16 | P80294 | |
| NCPTKCDKCHKTVKC | 316 | Q9Y6T7 | |
| DNKKCCVFSCGKKCL | 56 | O95925 | |
| FCICKKCCCKKKKNK | 81 | Q8N9I0 | |
| CCCCVKNKTVKDLKS | 61 | P0DKX4 | |
| KCKECKCTSCKKSCC | 21 | P13640 | |
| KCNKTGKKHDKLCCH | 241 | Q9Y6Q3 | |
| ASVCKLCKYACHKKC | 2026 | B2RTY4 | |
| LCKYACHKKCCLKTT | 2031 | B2RTY4 | |
| CHKKCCLKTTAKCSK | 2036 | B2RTY4 |